raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:786

Generalized glucocorticoid resistance syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Age of onset
All ages
Status
active

A rare, adrenogenital syndrome characterized by generalized, partial tissue insensitivity to glucocorticoids leading to variable phenotype, including asymptomatic individuals with only biochemical alterations or patients with ambiguous genitalia at birth in females, hypertension, acne, hirsutism, precocious puberty, male-pattern hair loss, anxiety and depression in both sexes, menstrual irregularities in women, and oligospermia in men.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enGeneralized glucocorticoid resistance syndrome
frSyndrome de résistance généralisée aux glucocorticoïdes
deGlukokortikoid-Resistenz, generalisierte
esSíndrome de resistencia generalizada a glucocorticoides
itSindrome da resistenza generalizzata ai glucocorticoidi
nlGegeneraliseerde glucocorticoïdresistentie-syndroom
ptSíndrome de resistência a glucocorticóides generalizada
plNiewrażliwość na glikokortykosteroidy
csRezistence ke glukokortikoidům
ukСиндром генералізованої глюкокортикоїдної резистентності
zh全身性糖皮质激素抵抗综合征
trJeneralize glukokortikoid direnç sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615962Evalidated
ICD-10E25.8NTBTattributedvalidated
ICD-115A71.00Especificvalidated
UMLSC5231034Evalidated
GARD2499Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NR3C1Disease-causing germline mutation(s) inAssessedHGNC:7978ENSG000001135801380405q31.3nuclear receptor subfamily 3 group C member 123076843[PMID]_19933394[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidated23392096[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

21 annotations · validated 2016-09-05
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0004319Decreased circulating aldosterone level
HP:0012378Fatigue
HP:0001007Hirsutism
HP:0003154Increased circulating ACTH level
HP:0012030Increased urinary cortisol level
Frequent (79-30%)
HP:0030087Abnormal testosterone level
HP:0001061Acne
HP:0008221Adrenal hyperplasia
HP:0000822Hypertension
HP:0002900Hypokalemia
HP:0200114Metabolic alkalosis
HP:0000876Oligomenorrhea
Occasional (29-5%)
HP:0000062Ambiguous genitalia
HP:0010458Female pseudohermaphroditism
HP:0002292Frontal balding
HP:0001943Hypoglycemia
HP:0003118Increased circulating cortisol level
HP:0000789Infertility
HP:0000798Oligozoospermia
HP:0000826Precocious puberty
Very rare (<4-1%)
HP:0001297Stroke

Run the differential on the 5 obligate / very frequent terms

Annotation source: 6282933[PMID]_3771797[PMID]_24483153[PMID]_8239231[PMID]_18319312[PMID]_11932321[PMID]

7

Sources for this card